Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 04-2015 | 04-2014 | 04-2013 | 04-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,661 | 7,927 | 58,321 | 784 | 1,880 |
| Marketable Securities | 16,529 | 9,200 | N/A | N/A | N/A |
| Receivables | 49 | 77 | 66 | 542 | 49 |
| Inventories | N/A | N/A | N/A | 99 | 83 |
| Other current assets | 0 | 59 | 177 | 171 | 163 |
| TOTAL | $20,560 | $17,511 | $58,966 | $1,842 | $2,631 |
| Non-Current Assets | |||||
| PPE Net | 36 | 50 | 124 | 205 | 294 |
| Investments And Advances | 18,019 | 30,975 | 0 | 0 | 0 |
| Intangibles | 33,265 | 33,265 | 34,265 | 925 | 873 |
| Other Non-Current Assets | 1,107 | 1,107 | 74 | 208 | 344 |
| TOTAL | $52,427 | $65,397 | $34,463 | $1,338 | $1,511 |
| Total Assets | $72,987 | $82,908 | $93,429 | $3,181 | $4,142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 973 | 1,184 | 411 | 977 | 543 |
| Accrued Expenses | 3,105 | 2,661 | 858 | 875 | 1,274 |
| Other current liabilities | 524 | 572 | 955 | N/A | 1,247 |
| TOTAL | $4,602 | $4,517 | $2,571 | $1,910 | $3,127 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,994 | 1,361 |
| Other Non-Current Liabilities | 0 | 0 | 11 | 55 | 0 |
| TOTAL | $7,962 | $7,962 | $7,973 | $3,049 | $1,361 |
| Total Liabilities | $12,564 | $12,479 | $10,544 | $4,959 | $4,488 |
| Shareholders' Equity | |||||
| Common Shares | 3 | 3 | 3 | 0 | 3 |
| Retained earnings | -160,736 | -150,668 | -136,586 | -117,044 | -107,628 |
| Other shareholders' equity | -129 | 27 | 0 | 0 | 0 |
| TOTAL | $60,423 | $70,429 | $82,885 | $-1,778 | $-346 |
| Total Liabilities And Equity | $72,987 | $82,908 | $93,430 | $3,181 | $4,142 |